The judge presiding over the federal Zoloft multidistrict litigation said that she could benefit from a court-appointed, "truly neutral expert," but that it is too early in the life of the litigation for such an expert to be appointed.
U.S. District Judge Cynthia M. Rufe of the Eastern District of Pennsylvania was speaking at the latest status conference Thursday in an MDL in which around 250 plaintiffs so far are prosecuting allegations that women’s use of the popular antidepressant during their pregnancies caused birth defects in their children.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
